Newborn screening for inborn errors of metabolism in mainland china: 30 years of experience.
about
Newborn screening and related policy against Phenylketonuria in ChinaHousehold financial burden of phenylketonuria and its impact on treatment in China: a cross-sectional study.Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan.An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.Screening for inherited metabolic diseases using gas chromatography-tandem mass spectrometry (GC-MS/MS) in Sichuan, China.Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing.Correlation between genotype and the tetrahydrobiopterin-responsive phenotype in Chinese patients with phenylketonuria.Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.Incidence and Interrelated Factors in Patients With Congenital Hypothyroidism as Detected by Newborn Screening in Guangxi, China.Inborn errors of metabolism: challenges and managementSubacute onset leukodystrophy and visual-spatial disorders revealing phenylketonuria combined with homocysteinmia in adulthood: A case report.Expanded Newborn Screening for Inborn Errors of Metabolism and Genetic Characteristics in a Chinese Population.Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.Research, diagnosis and education in inborn errors of metabolism in Colombia: 20 years' experience from a reference center
P2860
Q27012734-161E7DF8-3A58-4642-A6BA-37FD3D6593AAQ33568965-873DB81A-C4FC-40CE-B4D8-D845F23C6D97Q34377810-B17513EF-C4D1-4AEE-8EC3-004373FB538AQ35741264-0D4260F8-5F2A-4306-A32A-003342C54A69Q36124015-993D1FED-F31D-4C46-9ADE-F9D5E7F43F01Q36209473-ACEF5B54-3B50-4053-A45D-D61952CB0D51Q36426890-2A5DEA06-513C-4DBD-A7C5-8C15F344C22BQ36494431-FD272072-1D1D-45A8-BD34-87CA87B119BBQ36668732-17DB896E-51BA-4543-981F-B5C9CBE9C1E2Q37199418-DCA4BFA9-C4AA-4C84-8CA1-5E2330629A7EQ49712173-4A3E74A4-FD5A-430C-90D5-1363477B811AQ55018148-E06AD29C-8690-4272-A90D-99CC74DD4B8AQ55347435-09C58D1E-880A-487D-ADD3-C53802542A33Q58774196-D871F842-D982-4160-B8E7-C241DD64303F
P2860
Newborn screening for inborn errors of metabolism in mainland china: 30 years of experience.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Newborn screening for inborn e ...... china: 30 years of experience.
@ast
Newborn screening for inborn e ...... china: 30 years of experience.
@en
type
label
Newborn screening for inborn e ...... china: 30 years of experience.
@ast
Newborn screening for inborn e ...... china: 30 years of experience.
@en
prefLabel
Newborn screening for inborn e ...... china: 30 years of experience.
@ast
Newborn screening for inborn e ...... china: 30 years of experience.
@en
P2093
P2860
P356
P1476
Newborn screening for inborn e ...... china: 30 years of experience.
@en
P2093
Dao-Wen Wang
Li-Ming Gong
Peng-Wei Jing
Shao-Guang Fang
Wei-Peng Wang
Wen-Jun Tu
Xiao-Tong Shi
Yin-Tao Ye
Yuan-Yu Wang
P2860
P356
10.1007/8904_2011_119
P577
2012-01-31T00:00:00Z